Skip to contentM
Merit Medical Systems Inc
M
MMSIMerit Medical Systems Inc Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$393.94M$393.94Mderived+10.9% vs Q4 2024 Net Income$38.01M$38.01Mderived+36.0% vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Merit Medical Systems Inc · CIK 856982 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$195,352,000+12.9% Operating Incomederived$54,195,000+48.2% Operating Cash Flowderived$98,510,000+43.3% Free Cash Flowderived$74,046,000+13.4% Margins · derivedGross margin49.6%+0.9 pt vs Q4 2024
Operating margin13.8%+3.5 pt vs Q4 2024
Net margin9.6%+1.8 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 24, 2026 · 55 d after period end